Results 111 to 120 of about 2,243,245 (285)

BrECADD in three days: Implementation of a condensed intensive first‐line regimen in Hodgkin lymphoma

open access: yesBritish Journal of Haematology, EarlyView.
BrECADD can be delivered over 3 days instead of four, reducing intravenous treatment days by 25% without compromising dose intensity. Among 30 patients with advanced‐stage Hodgkin lymphoma, no unexpected toxicity was observed; there were no early discontinuations, and 1‐year progression‐free and overall survival were both 100%.
Christian Peter Jaworek   +16 more
wiley   +1 more source

Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort

open access: yesAsian Journal of Transfusion Science, 2011
Aim: This study was designed to analyze the incidence and spectrum of adverse effects of blood transfusion so as to initiate measures to minimize risks and improve overall transfusion safety in the institute. Materials and Methods: During the period from
Bhattacharya Prasun   +4 more
doaj  

Blood Transfusion Reactions in Elderly Patients Hospitalized in a Multilevel Geriatric Hospital

open access: yesJournal of Aging Research, 2014
Background/Objectives. Blood transfusion is a critical issue for patients with chronic diseases such as heart failure, chronic kidney disease, and malignancy. However, side effects are not rare.
E. Lubart   +4 more
doaj   +1 more source

Peanut‐Specific IgG4 mAbs Promote Regulatory Immune Responses Ex Vivo and Improve Oral Immunotherapy in Mice

open access: yesClinical &Experimental Allergy, EarlyView.
Allergen‐specific IgG4 mAbs were shown to block facilitated IgE binding to B cells and redirect allergens towards myeloid APC, leading to increased IL‐10 production in vitro. In combination with oral AIT, the mAbs inhibited mast cell activation and sustained allergen‐specific IgG4 levels in an in vivo model of peanut allergy. ABSTRACT Background Peanut
Pascal Gasser   +12 more
wiley   +1 more source

Underreporting of transfusion incidents

open access: yesHematology, Transfusion and Cell Therapy
Background: Blood transfusion is an effective therapeutic practice. However, even adopting all procedures for transfusion safety, there are risks, one of which is immediate adverse reactions.
Josiane Garcia   +5 more
doaj   +1 more source

HAEMOVIGILANCE IN SLOVENIA IN YEARS 2002–2006

open access: yesZdravniški Vestnik, 2008
BACKGROUND Adverse reactions and preventive actions have accompanied transfusion medicine fromits beginning. Because of this, a haemovigilance system is imperative.
Marjeta Potočnik
doaj  

Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational before‐and‐after study including the first non‐tunnelled CVC insertion ...
Mathias Lazarevic Lindblad   +8 more
wiley   +1 more source

Adverse reactions to red blood cell transfusion: incidence, classification and prevention strategies

open access: yes
La transfusión de concentrados de glóbulos rojos representa una intervención terapéutica fundamental en la práctica médica moderna, sin embargo, no está exenta de riesgos.
Sierra Peña, Dina Marcela   +1 more
core  

Annual SHOT Report 2013

open access: yes, 2023
SHOT is affiliated to the Royal College of PathologistsThe current risks from blood and blood component transfusion in the UK remains small with a risk of death at 8.0 and risk of major morbidity 51.8 per 1,000,000 components issued.
Serious Hazards of Transfusion (SHOT)
core  

Home - About - Disclaimer - Privacy